ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,490 | -93.5% | 1,000 | -94.9% | 0.00% | -95.8% |
| Q3 2022 | $313,000 | -1.9% | 19,657 | -15.5% | 0.02% | -17.2% |
| Q2 2022 | $319,000 | +2353.8% | 23,249 | +7649.7% | 0.03% | +2800.0% |
| Q2 2021 | $13,000 | -89.7% | 300 | -89.5% | 0.00% | -91.7% |
| Q1 2021 | $126,000 | +231.6% | 2,860 | +308.6% | 0.01% | +200.0% |
| Q4 2020 | $38,000 | +280.0% | 700 | 0.0% | 0.00% | +300.0% |
| Q2 2019 | $10,000 | +150.0% | 700 | +182.3% | 0.00% | – |
| Q1 2018 | $4,000 | – | 248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |